Europe

Article: Access to full trial data sets benefits industry

Friday, October 25, 2013 11:46 AM

Access to full data sets from clinical trials will benefit both large and small biopharmaceutical companies and researchers, according to an article published in the New England Journal of Medicine by four members of the EMA staff, including its executive director and senior medical officer. 

More... »

WIRB Copernicus Group

AstraZeneca proposes closing Brixham Environmental Laboratory

Friday, October 25, 2013 11:45 AM

AstraZeneca has announced proposals to close its Environmental Laboratory in Brixham, Devon, U.K. The laboratory, with 71 staff members, provides specialist services to assess the impact of pharmaceuticals and chemicals used by a range of industries on the environment.

More... »


Eight companies receive funding boost in NHS England’s SBRI Healthcare program

Wednesday, October 23, 2013 02:46 PM

SBRI Healthcare, an NHS England funded initiative to develop innovative products and services that address unmet health needs, has awarded eight companies phase I development funding in the latest SBRI competition supporting Mental Health and End of Life Innovations.

More... »

University of Cambridge, Genomics England, Illumina collaborate

Monday, October 21, 2013 01:36 PM

University of Cambridge, Genomics England and Illumina have announced the launch of a three-year project to sequence 10,000 whole genomes of children and adults with rare genetic diseases. The project is a pilot for Genomics England, which will provide 2,000 samples, and marks the beginning of the national endeavor to sequence 100,000 genomes in the U.K. National Health Service (NHS).

More... »

Sanofi, Merck participate in pilot for rapid European health technology assessment

Friday, October 18, 2013 11:06 AM

Sanofi Pasteur MSD is the first vaccine company to have successfully participated in a pilot testing a new rapid relative effectiveness assessment of health technologies in Europe.

More... »

EMA launches new version of EudraCT

Wednesday, October 16, 2013 10:15 AM

The European Medicines Agency (EMA) has launched a new version of the European Clinical Trials Database (EudraCT). This version, EudraCT V9, marks the initial step of a process through which summary clinical trial results will be made publicly available through the EU Clinical Trials Register (EU CTR).

More... »

Clinlogix acquires ikfe CRO for Eurpoean market expansion

Wednesday, October 16, 2013 09:38 AM

Global CRO Clinlogix has acquired ikfe CRO, a CRO headquartered in Mainz, Germany that serves the European market.

More... »

Greenphire appoints Alex Livingstone senior director of business development

Tuesday, October 15, 2013 09:29 AM

Greenphire, a provider of payment technologies for the clinical trials industry, has appointed Alex Livingstone senior director of business development in Europe. Livingstone brings more than 12 years of eClinical software, pharmaceutical and biotechnology industry experience to the company, in a move designed to help Greenphire extend its footprint in European markets.

More... »

Scottish drug approval process to become more transparent

Wednesday, October 9, 2013 11:50 AM

Scottish patients will benefit from an increased range of new medicines due to changes announced by Alex Neil, the Scottish health secretary.

More... »

Report: British pharmaceutical market to reach $31.7 billion by 2020

Monday, September 30, 2013 02:39 PM

A growing disease burden, universal coverage and good access to healthcare facilities are boosting the U.K. healthcare market, but increasing use of generics and government cost-cutting measures to reduce expenditure are restricting further growth, according to research and consulting firm GlobalData.

More... »

`
CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

August 25

Verizon Communications enters clinical trial space with technology, network, and cloud and data services

Sponsors look to the power of genomic profiling to screen, enroll patients in trials for targeted therapies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs